Hologic, Inc. engages in the development, manufacture, and supply of medical imaging systems and diagnostic and surgical products focused on the healthcare needs of women. Products The company operates in four segments: Breast Health; Diagnostics; GYN Surgical; and Skeletal Health. BREAST HEALTH PRODUCTS The company's breast health business offers a line of breast imaging products, including the Selenia full field digital mammography system, a series of screen-film mammography systems, breast biopsy image guidance systems, computer-aided detection (CAD) systems for both screen-film and digital mammography, and DirectRay digital detectors. Its breast health business also includes its Interventional Breast Solutions family of products including breast biopsy devices, its MammoSite radiation therapy system and the MammoPad breast cushion. The company's photoconductor coating business, which it acquired in connection with its acquisition of its selenium coating capabilities for its digital detectors, is also a component of its breast health business. DirectRay Digital Detector: The company's DirectRay flat panel detector technology employs an amorphous selenium (a-Se) photoconductor to directly convert x-ray photons into an electrical signal. Selenia Full Field Digital Mammography System: The Selenia full field digital mammography system is based on its proprietary, amorphous selenium DirectRay digital detector, which preserves image quality by using amorphous selenium to directly convert x-rays to electronic signals, without first converting them to light. This direct conversion process preserves image sharpness by eliminating light diffusion.

Research Grants 23 show all


$4.7M
2000

$3.9M
2007

$641.7K
2008

Publications 65 show all

  • 6
    DNA Probes
  • 6
    Reagent Kits, Diagnostic
  • 5
    Nucleic Acid Hybridization/methods
  • 4
    Acridines/chemistry
  • 4
    Antigens, Neoplasm/urine
  • 4
    HIV-1/isolation & purification
  • 4
    Prostatic Neoplasms/diagnosis
  • 3
    HIV-1/genetics
  • 3
    Hepacivirus/isolation & purification
  • 3
    Nucleic Acid Amplification Techniques

Patents 5,249show all

  • 1,290
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 962
    A61B - Diagnosis
  • 743
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 353
    B01L - Chemical or physical laboratory apparatus for general use
  • 286
    C12N - Microorganisms or enzymes
  • 239
    G06T - Image data processing or generation, in general
  • 191
    A61M - Devices for introducing media into, or onto, the body
  • 174
    A61N - Electrotherapy
  • 161
    G06K - Recognition of data
  • 139
    C07H - Sugars

Clinical Trials 57show all

16N/A2Phase 21Phase 31Phase 4

SEC Filings show all


235
8-K

75
10-Q

22
10-K

2
D

Contact Information

35 Crosby Drive
Bedford, MA 01730
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$450,000,00010000+2010-11-30Ipo

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2010-11-30$450,000,000Post Ipo Equity

SEC Form D Funding Events

DateOfferedSoldType
2010-11-24$450,000,000$450,000,000Debt
2006-08-10Unknown Unknown Other (Paper Filing)

Key Executives

  • John W. Cumming
    Executive Officer, Director
  • Robert A. Cascella
    Executive Officer, Director
  • Glenn P. Muir
    Executive Officer, Director
  • Sally W. Crawford
    Director
  • David R. LaVance, Jr.
    Director
  • Nancy L. Leaming
    Director
  • Lawrence M. Levy
    Director
  • Elaine S. Ullian
    Director
  • Wayne Wilson
    Director
  • David J. Brady
    Executive Officer
  • Mark J. Casey
    Executive Officer
  • David Harding
    Executive Officer
  • Peter K. Soltani
    Executive Officer
  • Jay A. Stein
    Executive Officer
  • Steve S. Williamson
    Executive Officer